WallStreetZenWallStreetZen

NASDAQ: KZR
Kezar Life Sciences Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for KZR

Based on 1 analyst offering 12 month price targets for Kezar Life Sciences Inc.
Min Forecast
$7.00+725.47%
Avg Forecast
$7.00+725.47%
Max Forecast
$7.00+725.47%

Should I buy or sell KZR stock?

Based on 1 analyst offering ratings for Kezar Life Sciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their KZR stock forecasts and price targets.

KZR stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-08-14

1 of 1

Forecast return on equity

Is KZR forecast to generate an efficient return?
Company
-50.6%
Industry
-784.34%
Market
48.93%
KZR's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is KZR forecast to generate an efficient return on assets?
Company
-42.38%
Industry
26.21%
KZR is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

KZR earnings per share forecast

What is KZR's earnings per share in the next 3 years based on estimates from 4 analysts?
Avg 1 year Forecast
-$1.20
Avg 2 year Forecast
-$0.97
Avg 3 year Forecast
-$1.00

KZR revenue forecast

What is KZR's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$12.0M+71.43%
Avg 2 year Forecast
$20.0M+185.71%
Avg 3 year Forecast
$9.3M+32.43%
KZR's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

KZR revenue growth forecast

How is KZR forecast to perform vs Biotechnology companies and vs the US market?
Company
20.97%
Industry
35.38%
Market
9.84%
KZR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
KZR's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

KZR vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
KZR$0.85$7.00+725.47%Buy
CSBR$4.54$6.00+32.16%Buy
CVM$1.01N/AN/A
AVTE$2.13$11.75+451.64%Hold
VANI$1.13N/AN/A
View Top Biotech Stocks

Kezar Life Sciences Stock Forecast FAQ

Is Kezar Life Sciences Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: KZR) stock is to Buy KZR stock.

Out of 1 analyst, 0 (0%) are recommending KZR as a Strong Buy, 1 (100%) are recommending KZR as a Buy, 0 (0%) are recommending KZR as a Hold, 0 (0%) are recommending KZR as a Sell, and 0 (0%) are recommending KZR as a Strong Sell.

If you're new to stock investing, here's how to buy Kezar Life Sciences stock.

What is KZR's earnings growth forecast for 2024-2026?

(NASDAQ: KZR) Kezar Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 13.54%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 18.87%.

Kezar Life Sciences's earnings in 2024 is -$98,568,000.On average, 4 Wall Street analysts forecast KZR's earnings for 2024 to be -$87,189,853, with the lowest KZR earnings forecast at -$99,228,619, and the highest KZR earnings forecast at -$70,773,353. On average, 4 Wall Street analysts forecast KZR's earnings for 2025 to be -$70,955,759, with the lowest KZR earnings forecast at -$103,606,352, and the highest KZR earnings forecast at -$32,832,999.

In 2026, KZR is forecast to generate -$72,962,220 in earnings, with the lowest earnings forecast at -$111,632,197 and the highest earnings forecast at -$34,292,243.

What is KZR's revenue growth forecast for 2024-2027?

(NASDAQ: KZR) Kezar Life Sciences's forecast annual revenue growth rate of 20.97% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 35.38%, and while it is forecast to beat the US market's average forecast revenue growth rate of 9.84%.

Kezar Life Sciences's revenue in 2024 is $7,000,000.On average, 1 Wall Street analysts forecast KZR's revenue for 2024 to be $875,546,640, with the lowest KZR revenue forecast at $875,546,640, and the highest KZR revenue forecast at $875,546,640. On average, 1 Wall Street analysts forecast KZR's revenue for 2025 to be $1,459,244,400, with the lowest KZR revenue forecast at $1,459,244,400, and the highest KZR revenue forecast at $1,459,244,400.

In 2027, KZR is forecast to generate $676,359,779 in revenue, with the lowest revenue forecast at $676,359,779 and the highest revenue forecast at $676,359,779.

What is KZR's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: KZR) forecast ROA is -42.38%, which is lower than the forecast US Biotechnology industry average of 26.21%.

What is KZR's Price Target?

According to 1 Wall Street analyst that have issued a 1 year KZR price target, the average KZR price target is $7.00, with the highest KZR stock price forecast at $7.00 and the lowest KZR stock price forecast at $7.00.

The Wall Street analyst predicted that Kezar Life Sciences's share price could reach $7.00 by Aug 14, 2025. The average Kezar Life Sciences stock price prediction forecasts a potential upside of 725.47% from the current KZR share price of $0.85.

What is KZR's Earnings Per Share (EPS) forecast for 2024-2026?

(NASDAQ: KZR) Kezar Life Sciences's current Earnings Per Share (EPS) is -$1.36. On average, analysts forecast that KZR's EPS will be -$1.20 for 2024, with the lowest EPS forecast at -$1.36, and the highest EPS forecast at -$0.97. On average, analysts forecast that KZR's EPS will be -$0.97 for 2025, with the lowest EPS forecast at -$1.42, and the highest EPS forecast at -$0.45. In 2026, KZR's EPS is forecast to hit -$1.00 (min: -$1.53, max: -$0.47).

What is KZR's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: KZR) forecast ROE is -50.6%, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.